Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/2010
05/12/2010CN101120944B Composition containing inhibitor of thromboxane synthetase and nitrate esters medicine
05/12/2010CN101113146B Process for the separation of blood fat recovery purpose-made monascus active ingredient
05/12/2010CN101112494B Medicine for treating coronary disease and method for preparing the same
05/12/2010CN101108198B Epimedium erigeron pharmaceutical composition
05/12/2010CN101104048B Compound medicine for pulse generating and treating coronary heart disease
05/12/2010CN101104012B Medicine for treating cardiovascular disease
05/12/2010CN101095813B Method for extracting liposoluble effective extracts from onion white
05/12/2010CN101095811B Polarity effective extracts from onion white and the extracting method thereof
05/12/2010CN101092405B Derivative of new benzothiadiazines, preparation method and usage
05/12/2010CN101088549B Chinese medicine preparation for treating arrhythmia and its preparation process and quality control method
05/12/2010CN101053626B Traditional Chinese medicine for treating coronary heart disease and angina pectoris and its preparation method
05/12/2010CN101049356B Pharmaceutical composition of containing puerarin and leaves of hawthorn
05/12/2010CN101028266B Lung medicine-feeding preparation containing Mulinong
05/12/2010CN101011561B Modern traditional Chinese medicine oral preparation huanglianwendan decoction and production method thereof
05/12/2010CN101011156B Cactus beverage with health care function for cardio-cerebrovascular
05/12/2010CN100998617B Quality control method for Xindakang preparation
05/11/2010US7714013 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
05/11/2010US7714003 Imidazo[2,1-b ]-1,3,4-thiadiazole sulfonamides
05/11/2010US7713999 Thrombin receptor antagonists
05/11/2010US7713992 adenosine receptor antagonists such as 2-(4-Methoxyphenyl)-9-benzylamino-10-cyano-s-triazolo[1,5-a]quinolin, used for treating respiratory system disorders, vision disorders, tumors, allergies or inflammatory disease, ischemia, hypoxia, arrhythmia or urogential disorders
05/11/2010US7713991 Imidazo[[1, 5-A] pyridine derivatives and methods for treating aldosterone mediated diseases
05/11/2010US7713982 8-chloro-3-pentyl-3,7-dihydro-1H-purine-2,6-dione: hyperlipoproteinaemia, dyslipidaemia, heart failure, hypercholesteraemia, atherosclerosis, arteriosclerosis, and hypertriglyceridaemia
05/11/2010US7713971 Antidiabetic agents; dyslipidemia; hhypoglycemic agents; atherosclerosis ; obesity; antiinflammatory agents; metabolism disorders
05/11/2010US7713963 Acylated indanyl amines and their use as pharmaceuticals
05/11/2010US7713538 Drug delivery from stents
05/11/2010CA2598516C Benzisoxazole derivatives
05/11/2010CA2461958C Combination dosage form containing a cholesterol-lowering agent, a renin-angiotensin inhibitor, and aspirin
05/11/2010CA2434670C Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
05/11/2010CA2422299C Triazole compounds useful as protein kinase inhibitors
05/11/2010CA2410177C Thrombin receptor antagonists
05/11/2010CA2341638C Use of a midkine inhibitor
05/11/2010CA2326401C Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
05/11/2010CA2318492C Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
05/06/2010WO2010050794A1 Cardioprotective effects of nutraceuticals isolated from nigella sativa seeds
05/06/2010WO2010050793A1 Uses of curculigo latifolia (c. latifolia) extracts
05/06/2010WO2010050525A1 Compound having tafia inhibitory activity
05/06/2010WO2010050445A1 Bicyclic compound
05/06/2010WO2010050436A1 Piperidine derivative, piperazine derivative and agent for treatment of disease involving central nervous system disorders
05/06/2010WO2010050435A1 Cyclohexylamine derivative containing phenyl group, and therapeutic agent for diseases accompanied by central nervous system disorders
05/06/2010WO2010050191A1 1,2-diazetidin-3-one derivative and pharmaceutical agent comprising same
05/06/2010WO2010050179A1 Prophylactic/ameliorating agent for adult diseases comprising 5-aminolevulinic acid, derivative of 5-aminolevulinic acid, or salt of 5-aminolevulinic acid or the derivative of 5-aminolevulinic acid as active ingredient
05/06/2010WO2010049954A1 Fatty acids for use as a medicament
05/06/2010WO2010049900A1 Statin nanoparticles
05/06/2010WO2010049841A1 7-azaspiro [3.5] nonane-7-carboxamide compounds as modulators of fatty acid amide hydrolase
05/06/2010WO2010049709A2 Therapeutic compositions
05/06/2010WO2010049705A2 Therapeutic compositions
05/06/2010WO2010049635A1 Tropane urea derivatives, preparation thereof and therapeutic application thereof as modulators of the activity of 11betahsd1
05/06/2010WO2010049466A1 Thienotriazolodiazepine derivatives active on apo a
05/06/2010WO2010049423A1 Effects of nitric oxide inhalation on long-term myocardial reperfusion injury
05/06/2010WO2010048955A1 Composition comprising a glycoside of a mono- or diacyiglycerol compound and an oil rich in n-3 polyunsaturated fatty acids, a method of producing the composition and use of the composition
05/06/2010WO2010030976A3 Methods and compositions for inhibiting atherosclerosis and vascular inflammation
05/06/2010WO2010030396A3 Novel shrna gene therapy for treatment of ischemic heart disease
05/06/2010WO2010017653A8 Gq protein competitive inhibitory polypeptides, preparation methods and uses thereof
05/06/2010WO2010017478A3 Pak1 agonists and methods of use
05/06/2010WO2010013144A3 Antihypertensive composition containing an extract of hymenocardia acida
05/06/2010WO2009145358A3 Medicament for the prophylaxis or treatment of hypertension
05/06/2010WO2009138600A3 Novel uses of d-mannopyranose derivatives activating angiogenesis
05/06/2010WO2009118359A3 Capsule for the prevention of cardiovascular diseases
05/06/2010WO2009013543A3 Targeted binging agents directed to kdr and uses thereof - 035
05/06/2010US20100113796 Indole derivatives as s1p1 receptor
05/06/2010US20100113750 Novel scavenger receptor
05/06/2010US20100113749 Novel scavenger receptor
05/06/2010US20100113742 Modified polypeptides stabilized in a desired conformation and methods for producing same
05/06/2010US20100113599 Amphipathic carboxylates for the treatment of immune-related disorders
05/06/2010US20100113591 Methods and compositions for treating amyloid-related diseases
05/06/2010US20100113587 use of abscissic acid to treat various diseases, including neurodegenerative and neuromuscular diseases
05/06/2010US20100113550 New Crystal Forms
05/06/2010US20100113544 Suppressant for cerebral infarction attributed to long-time ischemia
05/06/2010US20100113540 Azole and Thiazole Derivatives and Their Use
05/06/2010US20100113536 haloalkylsulfone substituted compounds useful for treating obesity and diabetes
05/06/2010US20100113522 COMPOUNDS FOR THE MODULATION OF PPARgamma ACTIVITY
05/06/2010US20100113517 Method for the treatment of fabry disease using pharmacological chaperones
05/06/2010US20100113514 Fused heterocyclic compounds as ion channel modulators
05/06/2010US20100113507 3-Tetrazolyl Indazoles, 3-Tetrazolyl Pyrazolopyridines, and use Thereof
05/06/2010US20100113506 Composition for preventing or treating thrombus- or embolus- associated disease
05/06/2010US20100113488 Macrocyclic factor viia inhibitors useful as anticoagulants
05/06/2010US20100113485 Piperidinylamino-thieno[2,3-D] Pyrimidine Compounds
05/06/2010US20100113473 Aryl amide compound as an acetyl coenzyme a carboxylase inhibitor
05/06/2010US20100113468 Quinazoline derivatives as kinase inhibitors
05/06/2010US20100113463 PTERIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
05/06/2010US20100113461 Substituted heterocyclic compounds
05/06/2010US20100113452 Compounds for treating pulmonary hypertension
05/06/2010US20100113449 Fused heterocyclic compounds as ion channel modulators
05/06/2010US20100113444 Prolyl hydroxylase inhibitors
05/06/2010US20100113441 Substituted imidazopyrimidines and triazolopyrimidines
05/06/2010US20100113435 Inhibitors of 11-beta-hydroxy steriod dehydrogenase type 1
05/06/2010US20100113433 N-Substituted Thiomorpholine Derivatives as the Inhibitors of Dipeptidyl Peptidase IV and the Pharmaceutical Uses Thereof
05/06/2010US20100113423 Modulators of Aldehyde Dehydrogenase and Methods of Use Thereof
05/06/2010US20100113418 Heterocyclic compound
05/06/2010US20100113417 Substituted Spiroamine Compounds
05/06/2010US20100113412 IMIDAZO[1,2-a]PYRIDINES AND THEIR USE AS PHARMACEUTICALS
05/06/2010US20100113406 Use of glucocorticoids for treatment of congestive heart failure
05/06/2010US20100113388 8-azaprostaglandin derivative compound and agent comprising the compound as active ingredient
05/06/2010US20100113384 Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections
05/06/2010US20100113377 Method of Treatment Using Alpha-1-Adrenergic Agonist Compounds
05/06/2010US20100113368 Cholesterol lowering protein hydrolysates
05/06/2010US20100113353 Method and composition for inhibiting cardiovascular cell proliferation
05/06/2010US20100113330 Tetrahydropyrido[4,3-d]pyrimidinone derivatives and methods of use thereof
05/06/2010US20100112634 Yeast strains autonomously producing steroids
05/06/2010US20100112101 Bio-availability/bio-efficacy enhancing activity of stevia rebaudiana and extracts and fractions and compounds thereof
1 ... 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 ... 1595